RecruitingPhase 2NCT07770464

Evaluating The Role Of Montelukast In Management Of Acute Bronchiolitis

Sponsor

Pakistan Institute of Medical Sciences

Enrollment

60 participants

Start Date

Jan 1, 2026

Study Type

INTERVENTIONAL

Conditions

Acute Bronchiolitis

Summary

This study aims to evaluate the role of Montelukast in management of acute Bronchiolitis in indoor patient and how this drug shortens the duration of admission and improves symptoms

Eligibility

Min Age: 4 WeeksMax Age: 2 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Montelukast and a drug called Placebo for people with acute bronchiolitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 4 Weeks to 2 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMontelukast

Administrating montelukast to experimental group and monitoring response

DRUGPlacebo

Placebo sugar granules administered orally once daily at night according to the same schedule as montelukast 4 mg sachet, in addition to standard supportive care for acute bronchiolitis